INTRODUCTION
============

Persistent Organic Pollutants (POPs) are well-known environmental contaminants including polychlorinated bisphenyls (PCBs) and organochlorine pesticides (OCPs). These chemical compounds bioaccumulate in adipose tissue and come into toxins in body \[[@b1-jlm-6-049]--[@b3-jlm-6-049]\]. Furthermore, POPs have long-lasting adverse effects in our body from food chains. POPs increase reactive oxygen species (ROS), and lead to cell inflammations and oxidative stress \[[@b4-jlm-6-049]--[@b6-jlm-6-049]\]. It has been documented that POPs are associated with chronic diseases such as cancers, cardiovascular diseases, neuro-degenerative disease, and respiratory diseases \[[@b7-jlm-6-049],[@b8-jlm-6-049]\]. Particularly, there are emerging evidences that these xenobiotics alter metabolic mechanism and elevate insulin resistance. It can be resulted in obesity, dyslipidemia, and type 2 diabetes \[[@b9-jlm-6-049]--[@b14-jlm-6-049]\]. In other words, POPs aggravate many chronic conditions through ingestion, and respiration. To our healthy life, it is important to reduce accumulating chemical agents in the human body.

Unfortunately, people are consistently exposed to various chemicals and these compounds accumulate in our body for several decades \[[@b15-jlm-6-049]\]. Accordingly, it is vital to avoid chemical materials exposure as well as to remove from the body. However, few studies on reducing POPs effectively from the body have been found in the literature. Traditionally, detoxification, toxin elimination intervention, has become well-used therapy to clean of intestine, alleviate toxic symptoms and lose weight \[[@b16-jlm-6-049]\]. As the pathway of removal of chemical agents is through urine and fecal elimination, detoxification approach diverse methods using fasting, laxatives and enzyme for specific period \[[@b1-jlm-6-049]\]. Though, it is preferable to natural methods than strict calorie restriction, intestine cleansing and using certain food or enzyme to discard noxious chemicals for health. As foods are the major sources of human toxic pollutants, detoxification intervention is an effective way of intaking foods containing lower POPs and decomposing toxin from the body naturally \[[@b17-jlm-6-049]\]. Therefore, we developed an integrated dietary and education program for toxin elimination.

Although these extensive therapies widespread utilizing remove toxins, it is controversy on effects and remedies of detoxification \[[@b1-jlm-6-049],[@b18-jlm-6-049]\]. Since physiological biomarkers which reflect body toxin level and objective outcome indicators were not measured, it is insufficient to prove the effects of intervention to remove toxins \[[@b18-jlm-6-049]\]. Thus, physiological indicators which confirmed to body's toxin level are necessary to measure the outcomes. It is widely established that serum *γ*-glutamyltransferase (GGT) is a biomarker of alcohol consumption, heart disease, hypertension and type 2 diabetes \[[@b19-jlm-6-049]--[@b21-jlm-6-049]\]. In addition, several studies suggested that increased GGT within its normal range can be predicted environmental pollutants \[[@b22-jlm-6-049],[@b23-jlm-6-049]\]. Glutathione as an antioxidant combine xenobiotics intracellular and move toward extracellular to metabolite (phase II). GGT which located in cell membrane get involved in glutathione activities which conjugated various environmental pollutants \[[@b24-jlm-6-049]\]. Thus, the overall burden of toxicants can measure by GGT. Considering numerous synthetic chemicals to which we are exposed, measuring of certain manufactured materials does not understand to identify accumulating toxins in human body.

As environmental pollutants bioaccumulate in fatty tissue, it is essential to investigate the relationship between serum GGT and body fat indicators. Therefore, the present study was conducted to explore the effects of dietary detoxification program on serum GGT, weight, body fat percentage, body fat mass, waist circumference, lipid profiles, blood pressure and fasting blood glucose in adults.

MATERIALS AND METHODS
=====================

1. Study setting, design and sampling
-------------------------------------

This prospective, single-armed, pre-post study was conducted from June 2013 to June 2015 at a health examination center and a public health center in Seoul, Korea. Participants who were willing to join the dietary detoxification program were recruited through advertisements.

The inclusion criteria were: (1) age of 20--75 years, (2) able to follow a dietary intervention during 3 weeks, (3) physical conditions confirmed by doctors. The exclusion criteria were: (1) physically hard persons who were not able to perform the dietary detoxification program including cancer patients, nutritional problems, and taking medications for severe diseases, (2) not favorably communicate with cognitive impairment, (3) involved another dietary treatment.

All participants (n = 91) were recruited through advertisements. Among of them screening test was done by inclusion and exclusion criteria. Eligible subjects took initial and final physical examination at 0 and 3 weeks. Excluding insufficient and dropped data during 3 weeks, finally 68 data was analyzed for the study ([Fig. 1](#f1-jlm-6-049){ref-type="fig"}).

In additional analysis, the participants were divided into 2 groups depending on metabolic syndrome criteria. Metabolic syndrome definition was three or more of the following: (1) increased waist circumference (≥90 cm in men, ≥85 cm in women), (2) increased triglycerides ≥150 mg/dL) or drug treatment for elevated triglycerides, (3) decreased HDL cholesterol level (\<40 mg/dL in men, \<50 mg/dL in women) or drug treatment aimed to increase HDL cholesterol; (4) elevated blood pressure, defined as systolic blood pressure (SBP) ≥130 mmHg or diastolic blood pressure (DBP) ≥85 mmHg, or antihypertensive drug treatment; and (5) elevated fasting blood glucose \>100 mg/dL or use of blood glucose lowering agents \[[@b25-jlm-6-049]\].

2. Dietary detoxification program
---------------------------------

### 1) Toxin elimination diet

This program is a comprehensive toxin elimination program for 3 weeks. Intake foods are (1) whole grains, (2) brown rice, (3) legumes, (4) nuts, (5) white fish, (6) non-antibiotic, cage-free poultry, (7) vegetables and fruits, (8) seaweed \[[@b26-jlm-6-049]\]. White fish and non-antibiotic, cage-free poultry that contain relatively low POPs among animal protein source foods were allowed by a comprehensive literature review. Foods are avoided including (1) polished grains, (2) red meats and eggs, (3) processed foods, (4) foods with artificial flavor enhancer, (5) alcohol, (6) instant foods. After dinner, food ingestion except water was avoided for lipolysis during 12 hours fasting. Drinking water 1--2 L during day time and having liquid diets for breakfast and dinner was encouraged.

### 2) Education

All subjects participated education session during 20 hours. The education sessions were composed of introduction of effect of toxic agents on the human body, the principles of dietary intervention, the ways of lifestyle modification, cooking recipes and proper manner of recording a diet diary. Additional or special exercises were prohibited during intervention periods. However, body stretching was recommended for a posture balance.

### 3) Self-monitoring

Self-monitoring is a useful method to aware oneself the goal to achieve and shows the process of change \[[@b27-jlm-6-049]\]. This continuous feedback is a key strategy to maintain dietary interventions. Participants recorded weight, meal menu, and activities every day. 24-hours food diary was written for nutritional analysis during 3 days.

### 4) Telephone and SNS follow-up

In addition to education, daily SNS follow-up was performed to enhance the protocol properly. All participants were given answering immediately about dietary intervention and the way of coping with difficult situations. Also, telephone checkup has done by weekly.

### 5) Group support

After 10 days from initial examination, we had a group meeting session to share their challenged problems and short-term goal achievement. Participants were given supportive message and expressed their feelings each other.

3. Data collection and measurement
----------------------------------

To evaluate the effects of dietary detoxification program, physical and laboratory indicators were measured. Physical examination including height, weight, waist circumference, body fat percentage, body fat mass, and blood pressure was assessed at week 0 and 3. For laboratory outcomes evaluation, serum GGT, LDL-cholesterol, HDL-cholesterol, triglyceride, total cholesterol, and fasting blood glucose, venous blood was collected in the morning after fasting 8 hours at initial and in 3 weeks.

The primary outcome was serum GGT. Secondary outcomes were weight, body fat percentage, body fat mass, waist circumference, lipid profiles, blood pressure and fasting blood glucose.

4. Data analysis
----------------

A descriptive analysis was done to summarize the characteristics and outcome variables using mean (standard deviation). Comparisons of the pre and post test were analyzed by using the paired *t*-test. Wilcoxon signed rank test was used to test the nonparametric. All tests were two-sided, and p-value \<.05 were considered to present statistically significant differences. 23.0 SPSS software was used for the analysis. Nutritional analysis was used by CAN-Pro professionals version 4.0.

5. Ethical considerations
-------------------------

This study was approved by institutional review board of the Seoul National University (IRB-2013--100), and informed consent was obtained from all subjects.

RESULTS
=======

The subjects had a mean age of 52.4 ± 11.7 years, females were 79.4%. All participants in this study had a mean body fat percentage 32.4 ± 8.0%, and their mean body fat mass was 21.7 ± 9.2 kg. The average of systolic blood pressure was 122.3 ± 16.0 mmHg, and diastolic blood pressure was 76.0 ± 10.3 mmHg. Fasting blood glucose average was 95.3 ± 23.7 mg/dL ([Table 1](#t1-jlm-6-049){ref-type="table"}).

[Table 2](#t2-jlm-6-049){ref-type="table"} shows the macro and micro nutrients intakes of the participants. Conventional dietary (before intervention) and toxin elimination diets intake energy was assessed 1400--1500 kcal that was not significant difference between pre and post intervention (p = .826). Carbohydrate, fat, cholesterol, and protein intakes were not statistical difference; however, their components ratio was significantly different. Dietary fiber (p = .014), vitamin C (p = .001), phosphorus (p = .013), potassium (p = .005) intakes were significantly increased in 3 weeks.

[Fig. 2](#f2-jlm-6-049){ref-type="fig"} demonstrates that changes of the serum GGT was correlated with reductions of the body fat percentage (r = .379, p = .001).body fat mass (r = .435, p = .000) and fasting blood glucose (r = .423, p = .000).

[Table 3](#t3-jlm-6-049){ref-type="table"} is shown the average of serum GGT was 24.5 ± 16.6 U/L before the intervention. After 3 weeks, reduction of serum GGT with statistical significance in all participants (p = .000). Body weight (p = .000), body fat percentage (p = .000), body fat mass (p = .000), waist circumference (p = .000), LDL-cholesterol (p = .000), HDL-cholesterol (p = .003), triglyceride (p = .001), total cholesterol (p = .000), systolic blood pressure (p = .028), and diastolic blood pressure (p = .025) of all participants were reduced with statistical significance except fasting blood glucose (p = .304) in one group.

In additional analysis, the subjects were divided into 2 groups depending on metabolic syndrome criteria. Metabolic syndrome group participants were 18, all the variables statistically significant decreased except HDL-cholesterol in 3 weeks. Total cholesterol (p = .049), fasting blood glucose (p = .002), and systolic blood pressure (p = .001) were significantly reduced comparison to non-metabolic syndrome group ([Table 3](#t3-jlm-6-049){ref-type="table"}).

DISCUSSION
==========

Detoxification is one of the wide-spread integrative interventions. Some studies insisted that detoxification intervention can eliminate the body pollutants while, several physicians are concerned about the effects and warning of its harm \[[@b28-jlm-6-049],[@b29-jlm-6-049]\]. Though some difficulties in standardized detoxification regimens, dietary detoxification intervention may effect on the health outcomes \[[@b16-jlm-6-049],[@b30-jlm-6-049]--[@b32-jlm-6-049]\].

First, we verified the overall toxic burden by using serum GGT. In this study, statistically significant associations were investigated between the changes of fat tissue and serum GGT level. Several studies reported that POPs can elevate the insulin resistance and increase the prevalence of metabolic syndrome or diabetes \[[@b10-jlm-6-049]--[@b12-jlm-6-049]\]. Lim et al. explained that exposure to POPs may induce the mitochondrial dysfunction and metabolic syndrome \[[@b9-jlm-6-049]\]. Moon et al. reported that one of the representative POPs, bisphenol, induces glucose intolerance and insulin resistance in mice \[[@b33-jlm-6-049]\]. Lee et al. identified that some chemical pollutants are dose-response relationship with the incidence of type 2 diabetes \[[@b13-jlm-6-049]\]. Previous studies reported that serum GGT level may be a predictor of diabetes and hypertension and also is associated with dietary factors \[[@b34-jlm-6-049]--[@b36-jlm-6-049]\]. Toxin elimination diets and education program can be decreased the adipose tissue, and serum GGT. Although we did not directly measure the body toxins, it is necessary to research of POPs burdens measuring of many exposal chemicals in the body.

Second, serum GGT, weight, body fat percentage, body fat mass, waist circumference, lipids profiles, and blood pressure were significantly decreased in 3 weeks. These results suggest that a comprehensive dietary detoxification program can positively effect on reducing serum GGT, anthropometric data, lipids profiles, and blood pressure in all participants. Fasting blood glucose was not significantly decreased when we compared the changes in one group. In other hands, when it is focused on the only metabolic syndrome group, total cholesterol, fasting blood glucose, and systolic blood pressure were significantly reduced. Although sample size was small, this detoxification program may influence on decreasing cholesterol, blood glucose and blood pressure among insulin resistance subjects. Seven subjects had taken blood glucose lowering agents in metabolic syndrome group. Among of them, some subjects would decrease the number of glucose lowering drugs. Thus, this dietary detoxification program affected not only on lowering blood glucose level, but reducing taking medicines. Particularly, HDL-cholesterol slightly decreased in 3 weeks in post intervention (p = .055). A large scale 30-months follow-up study demonstrated that rapid decrease of fat might be associated with HDL-cholesterol reduction \[[@b37-jlm-6-049]\]. In our study, HDL-cholesterol decline seems a temporary phenomenon resulted in fat reduction. In addition, HDL to total cholesterol ratio is a practical indicator in clinical setting \[[@b38-jlm-6-049]\]. In this study, the change of HDL cholesterol/total cholesterol ratio, it was not significant difference between pre and post intervention.

Finally, even though this dietary detoxification did not restrict the calorie intakes, participants had a low-calorie diets comparing to Koreans' dietary reference intakes. During toxin elimination diets, total intake energy and carbohydrate were almost similar to before intervention diets. A Literature review, low-calorie detoxifications diet decreased 15 toxicity scales and weight loss \[[@b16-jlm-6-049]\]. The vegetarian diets can be lowered several POPs level in type 2 diabetes \[[@b39-jlm-6-049]\]. However, a possible risk of detoxification diets could be nutritional imbalances, we need to consider of nutritional restriction diets \[[@b32-jlm-6-049]\]. There was no significant difference between pre and during macro-nutrients including carbohydrate, fat and protein in this study. The reason of decreased the body fat could be considered that animal fat and saturated fatty acids were decreased and dietary fiber was increased.

This dietary detoxification program could decrease serum GGT as a surrogate marker for overall toxic burden in the body. Anthropometric data and metabolic biomarkers were improved in adults. To our knowledge, detoxification may help to prevent the incidence of metabolic syndrome or type 2 diabetes. The integrated dietary and education detoxification program seemed to be a protective intervention for elimination of toxicants from the body.

![Flows of the study.](jlm-6-049f1){#f1-jlm-6-049}

![Correlations between changes in serum GGT, body fat percentage, body fat mass, and fasting blood glucose.](jlm-6-049f2){#f2-jlm-6-049}

###### 

General characteristics and anthropometric data in each group

  Characteristics                   Total (N = 68)         Metabolic Syndrome (n = 18)   Non-metabolic Syndrome (n = 50)   p-value
  --------------------------------- ---------------------- ----------------------------- --------------------------------- ---------
  Age (years)                       52.4 ± 11.5 (20--74)   52.7 ± 10.6                   51.3 ± 15.0                       0.081
  Sex (male/female)                 14/54                  5/13                          9/41                              0.498
  Height (cm)                       160.0 ± 6.9            161.2 ± 6.4                   159.6 ± 7.1                       0.424
  Weight (kg)                       65.1 ± 14.9            72.1 ± 15.8                   62.5 ± 13.8                       0.019
  Body fat percentage (%)           32.4 ± 8.0             35.1 ± 6.0                    31.5 ± 8.5                        0.130
  Body fat mass (kg)                21.7 ± 9.2             25.8 ± 9.0                    20.2 ± 9.0                        0.016
  Body Mass Index (kg/m^2^)         25.3 ± 4.9             27.6 ± 4.9                    24.5 ± 4.7                        0.016
  Waist circumference (cm)          84.5 ± 11.8            91.3 ± 10.0                   82.2 ± 11.6                       0.003
  Total cholesterol (mg/dL)         196.0 ± 38.4           207.2 ± 32.5                  192.0 ± 39.9                      0.154
  LDL-cholesterol (mg/dL)           111.8 ± 34.2           120.3 ± 32.4                  108.8 ± 34.7                      0.251
  HDL-cholesterol (mg/dL)           58.8 ± 14.3            54.6 ± 17.4                   60.3 ± 12.8                       0.034
  Triglyceride (mg/dL)              124.7 ± 68.3           173.7 ± 75.0                  107.1 ± 56.9                      0.000
  Systolic blood pressure (mmHg)    122.3 ± 16.0           137.1 ± 15.3                  116.9 ± 12.6                      0.000
  Diastolic blood pressure (mmHg)   76.0 ± 10.3            82.0 ± 12.0                   73.8 ± 8.8                        0.009
  Fasting blood glucose (mg/dL)     95.3 ± 23.7            116.8 ± 36.1                  87.5 ± 9.0                        0.000

Mean ± SD or number.

A significant difference between groups, p-value for Mann-Whitney U test or chi-square test.

###### 

Comparison of macro and micro intake nutrients composition

  Nutrients                        Conventional diets (before interventions)   Toxin elimination diets (after intervention)   p-value
  -------------------------------- ------------------------------------------- ---------------------------------------------- ---------
  Energy (kcal)                    1445.0 ± 340.8                              1423.4 ± 230.7                                 .826
  Carbohydrate (g)                 244.5 ± 70.9                                255.8 ± 46.3                                   .570
  Fat (g)                          30.3 ± 8.2                                  28.2 ± 8.4                                     .445
  Animal fat (g)                   14.2 ± 6.4                                  6.4 ± 5.3                                      .002
  Vegetable fat (g)                16.1 ± 3.9                                  21.8 ± 7.8                                     .007
  Cholesterol (g)                  233.5 ± 130.4                               148.0 ± 107.9                                  .062
  Total fatty acid (g)             17.5 ± 7.5                                  13.3 ± 5.7                                     .057
  Saturated Fatty acids (g)        5.9 ± 4.2                                   3.3 ± 2.3                                      .049
  Mono-Saturated Fatty acids (g)   7.2 ± 4.3                                   5.0 ± 2.9                                      .114
  Poly-Saturated Fatty acids (g)   5.6 ± 2.4                                   6.2 ± 3.1                                      .447
  Protein (g)                      52.9 ± 14.2                                 53.1 ± 9.6                                     .971
  Plant protein (g)                30.3 ± 6.0                                  40.5 ± 9.6                                     .001
  Animal protein (g)               22.6 ± 11.5                                 12.6 ± 9.8                                     .020
  Dietary fiber (g)                20.8 ± 8.2                                  27.0 ± 7.3                                     .014
  Vitamin A (ug)                   990.6 ± 321.7                               1226.6 ± 868.4                                 .201
  Vitamin D (ug)                   2.4 ± 3.0                                   1.4 ± 1.2                                      .237
  Vitamin E (ug)                   12.8 ± 5.0                                  14.3 ± 4.4                                     .340
  Vitamin K (ug)                   233.2 ± 133.5                               229.9 ± 161.8                                  .939
  Vitamin C (ug)                   114.2 ± 52.6                                172.4 ± 80.7                                   .001
  Vitamin B6 (ug)                  1.6 ± 0.8                                   1.9 ± 0.4                                      .157
  Vitamin B12 (ug)                 5.7 ± 4.1                                   4.0 ± 1.9                                      .195
  Folate (ug)                      454.5 ± 107.1                               534.6 ± 194.7                                  .068
  Calcium (mg)                     410.4 ± 122.0                               392.5 ± 129.4                                  .624
  Phosphorus (mg)                  886.3 ± 207.3                               1022.8 ± 166.0                                 .013
  Sodium (mg)                      2963.2 ± 874.1                              2450.3 ± 967.2                                 .108
  Potassium (mg)                   2830.0 ± 1225.2                             3965.0 ± 1289.7                                .005
  Magnesium (mg)                   84.6 ± 63.5                                 93.2 ± 35.4                                    .593

Mean ± SD.

A significant difference between before and after intervention, p-value for independent t-test.

###### 

Clinical outcomes of the study participants between metabolic syndrome and non-metabolic syndrome group

  Clinical outcomes                 Total (N = 68)   Metabolic Syndrome (n = 18)                              Non-metabolic Syndrome (n = 50)   p-value                                                                                                                          
  --------------------------------- ---------------- -------------------------------------------------------- --------------------------------- -------------------------------------------------------- -------------- -------------------------------------------------------- -------
  Weight (kg)                       65.1 ± 14.9      62.8 ± 14.0[\*](#tfn7-jlm-6-049){ref-type="table-fn"}    72.1 ± 15.8                       69.2 ± 14.6[\*](#tfn7-jlm-6-049){ref-type="table-fn"}    62.5 ± 13.8    60.5 ± 13.2[\*](#tfn7-jlm-6-049){ref-type="table-fn"}    0.064
  Body fat percentage (%)           32.4 ± 8.0       31.2 ± 7.8[\*](#tfn7-jlm-6-049){ref-type="table-fn"}     35.1 ± 6.0                        33.7 ± 6.7[\*](#tfn7-jlm-6-049){ref-type="table-fn"}     31.5 ± 8.5     30.3 ± 8.1[\*](#tfn7-jlm-6-049){ref-type="table-fn"}     0.626
  Body fat mass (kg)                21.7 ± 9.2       20.1 ± 8.5[\*](#tfn7-jlm-6-049){ref-type="table-fn"}     25.8 ± 9.0                        23.8 ± 8.5[\*](#tfn7-jlm-6-049){ref-type="table-fn"}     20.2 ± 9.0     18.8 ± 8.2[\*](#tfn7-jlm-6-049){ref-type="table-fn"}     0.263
  Body Mass Index (kg/m^2^)         25.3 ± 4.9       24.4 ± 4.6[\*](#tfn7-jlm-6-049){ref-type="table-fn"}     27.6 ± 4.9                        26.5 ± 4.6[\*](#tfn7-jlm-6-049){ref-type="table-fn"}     24.5 ± 4.7     23.7 ± 4.4[\*](#tfn7-jlm-6-049){ref-type="table-fn"}     0.073
  Waist circumference (cm)          84.5 ± 11.8      81.8 ± 11.2[\*](#tfn7-jlm-6-049){ref-type="table-fn"}    91.3 ± 10.0                       88.9 ± 9.8[\*](#tfn7-jlm-6-049){ref-type="table-fn"}     82.2 ± 11.6    79.4 ± 10.8[\*](#tfn7-jlm-6-049){ref-type="table-fn"}    0.636
  Serum GGT(U/L)                    24.5 ± 16.6      17.9 ± 10.7[\*](#tfn7-jlm-6-049){ref-type="table-fn"}    33.7 ± 21.6                       24.7 ± 15.9[\*](#tfn7-jlm-6-049){ref-type="table-fn"}    21.2 ± 13.1    15.5 ± 6.7[\*](#tfn7-jlm-6-049){ref-type="table-fn"}     0.098
  Total cholesterol (mg/dl)         196.0 ± 38.4     174.5 ± 30.9[\*](#tfn7-jlm-6-049){ref-type="table-fn"}   207.2 ± 32.5                      175.7 ± 33.1[\*](#tfn7-jlm-6-049){ref-type="table-fn"}   192.0 ± 39.9   174.0 ± 30.4[\*](#tfn7-jlm-6-049){ref-type="table-fn"}   0.049
  LDL-cholesterol (mg/dl)           111.8 ± 34.2     98.9 ± 29.8[\*](#tfn7-jlm-6-049){ref-type="table-fn"}    120.3 ± 32.4                      100.3 ± 32.4[\*](#tfn7-jlm-6-049){ref-type="table-fn"}   108.8 ± 34.7   98.3 ± 29.2[\*](#tfn7-jlm-6-049){ref-type="table-fn"}    0.237
  HDL-cholesterol (mg/dl)           58.8 ± 14.3      55.4 ± 13.9[\*](#tfn7-jlm-6-049){ref-type="table-fn"}    54.6 ± 17.4                       49.1 ± 13.6                                              60.3 ± 12.8    57.6 ± 13.5[\*](#tfn7-jlm-6-049){ref-type="table-fn"}    0.504
  Triglyceride (mg/dl)              124.7 ± 68.3     98.3 ± 52.7[\*](#tfn7-jlm-6-049){ref-type="table-fn"}    173.7 ± 75.0                      132.8 ± 73.4[\*](#tfn7-jlm-6-049){ref-type="table-fn"}   107.1 ± 56.9   85.8 ± 36.5[\*](#tfn7-jlm-6-049){ref-type="table-fn"}    0.131
  Systolic blood pressure (mmHg)    122.3 ± 16.0     118.6 ± 14.7[\*](#tfn7-jlm-6-049){ref-type="table-fn"}   137.1 ± 15.3                      124.4 ± 18.7[\*](#tfn7-jlm-6-049){ref-type="table-fn"}   116.9 ± 12.6   116.5 ± 12.5                                             0.001
  Diastolic blood pressure (mmHg)   76.0 ± 10.3      73.3 ± 10.2[\*](#tfn7-jlm-6-049){ref-type="table-fn"}    82.0 ± 12.0                       76.8 ± 11.7[\*](#tfn7-jlm-6-049){ref-type="table-fn"}    73.8 ± 8.8     72.1 ± 9.4                                               0.075
  Fasting blood glucose (mg/dl)     95.3 ± 23.7      93.5 ± 16.1                                              116.8 ± 36.1                      105.2 ± 25.0[\*](#tfn7-jlm-6-049){ref-type="table-fn"}   87.5 ± 9.0     89.2 ± 8.2                                               0.002

Mean ± SD.

Between groups comparison, Mann-Whitney U test, p \< 0.05.

Within group comparison, Wilcoxon signed rank test, p \< 0.05.
